3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Cardiotoxicity
6
Lymphoma, Non-Hodgkin
4
Lymphoma
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Multiple Myeloma
2
Leukemia
2
Cardiovascular Diseases
2
Small Cell Lung Carcinoma
1
Obesity
1
Neoplasms
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Metastatic Solid Tumors
1
Metabolic Syndrome
1
Melanoma
1
Lymphoproliferative Disorders
1
Lymphomatoid Granulomatosis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Primary Effusion
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Lymphoma, AIDS-Related
1
Lung Neoplasms
1
Leukemia, Hairy Cell
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Heart Failure
1
Epstein-Barr Virus Infections
1
Interventions
Metformin
2
semaglutide
1
maltodextrin
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Walking
1
Vascular Stiffness
1
Topiramate
1
Tirzepatide
1
Qsymia
1
Pulse Wave Analysis
1
Phentermine
1
Observation
1
Naltrexone
1
Liraglutide
1
Inositol
1
Glucagon-Like Peptide-1 Receptor
1
Exercise
1
Electrocardiography
1
Echocardiography
1
Diethylpropion
1
Diet, Reducing
1
Diet Therapy
1
Contraceptives, Oral
1
Caloric Restriction
1
Bupropion
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metabolic Syndrome
×
Echocardiography
×
1 year
×
Clear all
NCT07041827
2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
217 enrolled